LRMR
Larimar Therapeutics (LRMR)
$12
About Larimar Therapeutics (LRMR)
Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.
Details
Daily high
$6.31
Daily low
$6.01
Price at open
$6.20
52 Week High
$13.68
52 Week Low
$3.80
Market cap
389.9M
Dividend yield
0.00%
Volume
103,239
Avg. volume
715,222
P/E ratio
-5.31
Larimar Therapeutics News
Details
Daily high
$6.31
Daily low
$6.01
Price at open
$6.20
52 Week High
$13.68
52 Week Low
$3.80
Market cap
389.9M
Dividend yield
0.00%
Volume
103,239
Avg. volume
715,222
P/E ratio
-5.31